8247 Stock Overview
Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Biosino Bio-Technology and Science Incorporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.85 |
52 Week High | HK$1.24 |
52 Week Low | HK$0.48 |
Beta | -0.17 |
1 Month Change | 3.66% |
3 Month Change | 26.87% |
1 Year Change | -19.81% |
3 Year Change | -33.59% |
5 Year Change | -37.50% |
Change since IPO | -68.81% |
Recent News & Updates
Biosino Bio-Technology and Science Incorporation (HKG:8247) Held Back By Insufficient Growth Even After Shares Climb 46%
Apr 22Is Biosino Bio-Technology and Science Incorporation (HKG:8247) Using Debt In A Risky Way?
Apr 01Biosino Bio-Technology and Science Incorporation's (HKG:8247) 31% Dip In Price Shows Sentiment Is Matching Revenues
Feb 08Recent updates
Biosino Bio-Technology and Science Incorporation (HKG:8247) Held Back By Insufficient Growth Even After Shares Climb 46%
Apr 22Is Biosino Bio-Technology and Science Incorporation (HKG:8247) Using Debt In A Risky Way?
Apr 01Biosino Bio-Technology and Science Incorporation's (HKG:8247) 31% Dip In Price Shows Sentiment Is Matching Revenues
Feb 08Some Confidence Is Lacking In Biosino Bio-Technology and Science Incorporation (HKG:8247) As Shares Slide 38%
Jul 31We Think That There Are Issues Underlying Biosino Bio-Technology and Science Incorporation's (HKG:8247) Earnings
Aug 19Shareholder Returns
8247 | HK Biotechs | HK Market | |
---|---|---|---|
7D | -5.6% | -3.1% | 1.3% |
1Y | -19.8% | -33.9% | 1.6% |
Return vs Industry: 8247 exceeded the Hong Kong Biotechs industry which returned -33.9% over the past year.
Return vs Market: 8247 underperformed the Hong Kong Market which returned 1.6% over the past year.
Price Volatility
8247 volatility | |
---|---|
8247 Average Weekly Movement | 11.7% |
Biotechs Industry Average Movement | 9.5% |
Market Average Movement | 7.5% |
10% most volatile stocks in HK Market | 15.7% |
10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 8247's share price has been volatile over the past 3 months.
Volatility Over Time: 8247's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1988 | 537 | Peng Chen | www.sinobio.com.cn |
Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. It offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. The company also provides medical and medical inspection services; produces and sells medical instruments; and researches and develops, sells, and distributes biological reagents and instruments.
Biosino Bio-Technology and Science Incorporation Fundamentals Summary
8247 fundamental statistics | |
---|---|
Market cap | HK$123.00m |
Earnings (TTM) | -HK$12.56m |
Revenue (TTM) | HK$311.67m |
0.4x
P/S Ratio-9.8x
P/E RatioIs 8247 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8247 income statement (TTM) | |
---|---|
Revenue | CN¥289.07m |
Cost of Revenue | CN¥161.71m |
Gross Profit | CN¥127.37m |
Other Expenses | CN¥139.01m |
Earnings | -CN¥11.65m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.08 |
Gross Margin | 44.06% |
Net Profit Margin | -4.03% |
Debt/Equity Ratio | 61.7% |
How did 8247 perform over the long term?
See historical performance and comparison